Eli Lilly & Co. stock underperforms Friday when compared to competitors
Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow Jones Industrial Average DJIA falling 0.37% to 44,546.08.
The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 36.07% higher than today’s price of $756.99. Of the 26 analysts covering Eli Lilly ...
With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...
Eli Lilly (LLY ... and near-term stock price movements. For the current quarter, Lilly is expected to post earnings of $5.43 per share, indicating a change of +118.1% from the year-ago ...
Eli Lilly and Company (NYSE:LLY) will increase its dividend from last year's comparable payment on the 10th of March to $1.50. This takes the annual payment to 0.8% of the current stock ...
the valuation may be even more justifiable as Eli Lilly stock trades at a price/earnings-to-growth (PEG) multiple of around 0.75. Anything below a PEG of 1 is generally considered a good ...
Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.
Eli Lilly unexpectedly ... with a price/earnings-to-growth ratio (PEG ratio) of 0.3. PEGs below 1 are generally considered undervalued, so on that basis, the stock is very cheap.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback